Cardiff Oncology Balance Sheet Health

Financial Health criteria checks 6/6

Cardiff Oncology has a total shareholder equity of $49.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $62.9M and $13.5M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$57.67m
EquityUS$49.39m
Total liabilitiesUS$13.50m
Total assetsUS$62.90m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: XE7C's short term assets ($59.3M) exceed its short term liabilities ($12.5M).

Long Term Liabilities: XE7C's short term assets ($59.3M) exceed its long term liabilities ($979.0K).


Debt to Equity History and Analysis

Debt Level: XE7C is debt free.

Reducing Debt: XE7C had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: XE7C has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: XE7C has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 19.5% each year.


Discover healthy companies